Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Perez, Tamra
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis May 2024 - Aug 2024 : Topline data for IPF Jan 2023 - Mar 2023 : Enrollment completion of TETON trial for IPF	Recruiting	3	576	Canada, US	Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer	United Therapeutics	Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease	06/25	06/25
PEARL, NCT04193592: Efficacy and Safety of Pirfenidone Treatment in HPS-ILD	Not yet recruiting	2	50	US	Pirfenidone, Esbriet	Jesse Roman, Genentech, Inc.	Hermansky Pudlak Syndrome, Interstitial Lung Disease	12/22	12/22
George, Gautam
TETON, NCT04708782: Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis May 2024 - Aug 2024 : Topline data for IPF Jan 2023 - Mar 2023 : Enrollment completion of TETON trial for IPF	Recruiting	3	576	Canada, US	Placebo, Inhaled Treprostinil, Tyvaso, Treprostinil Ultrasonic Nebulizer	United Therapeutics	Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease	06/25	06/25
Reardon, Lori
No trials found
Singh, Disha
No trials found
George, Guatam
No trials found